journal
Journals Cardiovascular Revascularizati...

Cardiovascular Revascularization Medicine : Including Molecular Interventions

https://read.qxmd.com/read/38724407/the-imprecision-of-measuring-activated-clotting-time-act-from-the-guiding-catheter-during-percutaneous-coronary-interventions
#41
LETTER
Aviv Y Pollak, Ofer M Kobo, Gilad Margolis, Majdi Saada, Erick Sanchez-Jimenez, Rami Abu Fanne, Yaniv Levi, Maguli Barel, Adeeb Abu-Akel, Ariel Roguin
BACKGROUND: Finding the balance between the reduction in ischemic events and bleeding complications is crucial for the success of percutaneous coronary intervention (PCI). The activated clotting time (ACT) is used routinely worldwide to monitor and titrate anticoagulation therapy with unfractionated heparin (UFH) during the procedure. OBJECTIVES: We aimed to test the accuracy of ACT measurements from the guiding catheter compared to the arterial access sheath. METHODS: Patients undergoing PCI with UFH therapy were prospectively enrolled...
May 6, 2024: Cardiovascular Revascularization Medicine: Including Molecular Interventions
https://read.qxmd.com/read/38719631/myocardial-revascularization-are-we-gaining-clarity-or-more-confusion
#42
EDITORIAL
Spencer B King
No abstract text is available yet for this article.
May 6, 2024: Cardiovascular Revascularization Medicine: Including Molecular Interventions
https://read.qxmd.com/read/38719633/markedly-elevated-high-sensitivity-troponin-and-in-hospital-mortality-after-cardiac-surgery
#43
JOURNAL ARTICLE
Pavan Reddy, Matteo Cellamare, Ilan Merdler, Cheng Zhang, Sukhdeep Bhogal, Amer I Aladin, Itsik Ben-Dor, Lowell F Satler, Toby Rogers, Ron Waksman
BACKGROUND: High-sensitivity troponin (hsTnI) is correlated with cardiac mortality; however, studies on the relationship of markedly elevated hsTnI with in-hospital mortality after cardiac surgery are sparse. Therefore, we aimed to define this relationship in order to help guide in-hospital, acute management of post-surgical patients. METHODS: We retrospectively analyzed all cardiac surgeries completed at our institution between January 2020 and June 2022 in which a peak hsTnI was noted to be >35× upper limit of normal (ULN = 34 ng/L)...
May 5, 2024: Cardiovascular Revascularization Medicine: Including Molecular Interventions
https://read.qxmd.com/read/38719632/conduction-disorders-following-transcatheter-aortic-valve-replacement-using-acurate-neo2-transcatheter-heart-valve-a-propensity-matched-analysis
#44
JOURNAL ARTICLE
Itamar Loewenstein, Ariel Finkelstein, Shmuel Banai, Amir Halkin, Maayan Konigstein, Jeremy Ben-Shoshan, Yaron Arbel, Israel Barbash, Amit Segev, Planner David, Gabby Elbaz-Greener, Hana Assa-Vaknin, Ran Kornowski, Danny Dvir, Elad Asher, Arie Steinvil
BACKGROUND: The ACURATE neo2 transcatheter aortic valve was developed to improve paravalvular leak (PVL) rates while maintaining low rates of conduction disturbances and permanent pacemaker implantation (PPMI) seen with its predecessor. We aimed to compare conduction disturbances rates of transcatheter aortic valve replacement (TAVR) using ACURATE Neo2 with other commonly used valves. METHODS: A retrospective analysis of the Israeli TAVR registry between the years 2014-2023 was performed to compare conduction disturbances and PVL rates, and procedural outcomes, among patients treated with ACURATE neo2, Edwards Sapien 3 (S3), and Evolut PRO valves...
May 5, 2024: Cardiovascular Revascularization Medicine: Including Molecular Interventions
https://read.qxmd.com/read/38719630/impact-of-coronary-artery-disease-and-revascularization-on-outcomes-of-transcatheter-aortic-valve-replacement-for-severe-aortic-stenosis
#45
JOURNAL ARTICLE
Yoshiyuki Yamashita, Serge Sicouri, Massimo Baudo, Aleksander Dokollari, Roberto Rodriguez, Eric M Gnall, Paul M Coady, Harish Jarrett, Sandra V Abramson, Katie M Hawthorne, Scott M Goldman, William A Gray, Basel Ramlawi
BACKGROUND/PURPOSE: To evaluate the impact of coronary artery disease (CAD), percutaneous coronary intervention (PCI), and coronary lesion complexity on outcomes of transcatheter aortic valve replacement (TAVR) for aortic stenosis. METHODS/MATERIALS: This retrospective study included 1042 patients divided into two groups by the presence or absence of CAD (SYNTAX score 0, no history of revascularization). Propensity score matching was used to compare the two groups...
May 5, 2024: Cardiovascular Revascularization Medicine: Including Molecular Interventions
https://read.qxmd.com/read/38714398/editorial-going-from-evolut-pro-to-evolut-fx-a-step-in-the-right-direction
#46
EDITORIAL
Sachin S Goel, Joe Aoun, Michael J Reardon
No abstract text is available yet for this article.
May 3, 2024: Cardiovascular Revascularization Medicine: Including Molecular Interventions
https://read.qxmd.com/read/38697884/combined-use-of-intra-aortic-balloon-pump-and-impella-in-cardiogenic-shock-a-systematic-review
#47
REVIEW
Jacopo Farina, Andrea Erriquez, Gianluca Campo, Simone Biscaglia, Marco Zuin, Gianni Casella, Alessandro Capecchi, Giampiero Nobile, Federico Pappalardo
BACKGROUND: Use of Intra-Aortic Balloon Pump (IABP) in combination with Impella has been described as an alternative strategy for mechanical circulatory support (MCS) in patients with cardiogenic shock (CS). We provide a systematic review aimed to explore the effectiveness of this paired MCS approach. METHODS: We conducted a comprehensive systematic search in MEDLINE, Scopus, and Cochrane databases to identify all studies that investigated dual MCS with IABP and Impella...
April 25, 2024: Cardiovascular Revascularization Medicine: Including Molecular Interventions
https://read.qxmd.com/read/38679500/optimal-timing-of-percutaneous-coronary-intervention-for-non-st-elevated-myocardial-infarction-with-congestive-heart-failure
#48
JOURNAL ARTICLE
Yongwhan Lim, Min Chul Kim, Joon Ho Ahn, Seung Hun Lee, Dae Young Hyun, Kyung Hoon Cho, Doo Sun Sim, Young Joon Hong, Ju Han Kim, Myung Ho Jeong, Ik Jun Choi, Eun Ho Choo, Sungmin Lim, Byung-Hee Hwang, Mahn-Won Park, Chan Joon Kim, Chul Soo Park, Hee Yeol Kim, Kiyuk Chang, Youngkeun Ahn
OBJECTIVES: This study investigated the optimal timing for percutaneous coronary intervention (PCI) in patients with NSTEMI complicated by heart failure (HF). METHODS: In total, 762 patients with NSTEMI and HF in a multicenter, prospective registry in South Korea were classified according to the Killip classification (Killip class 2, n = 414 and Killip class 3, n = 348) and underwent early (within 24 h) and delayed (after 24 h) PCI...
April 25, 2024: Cardiovascular Revascularization Medicine: Including Molecular Interventions
https://read.qxmd.com/read/38704325/ct-guided-ozone-mediated-lumbar-renal-sympathetic-denervation-for-resistant-hypertension-treatment-a-pilot-single-arm-clinical-trial
#49
JOURNAL ARTICLE
Li Li, Jia Liu, Bin Huang, Yizhi Zhang, Fang Zeng, Pingge Tian, Xiwei Chen, Biao Li, Yarong Wang, Hui Yang, Xiao Xiao, Song Chen, Pan Jiang, Jiashuang Wang, Yihui Huang
BACKGROUND: Renal sympathetic denervation (RDN) reduces blood pressure (BP). METHODS: This single-arm open-label study enrolled patients with resistant hypertension (RH) and treat them by CT-guided ozone mediated lumbar-renal sympathetic denervation (L-RDN). The primary endpoint was to assess the changes of BP over 24-h ambulatory BP monitoring (ABPM) and to evaluate the anti-hypertensive medication burden (AHMB) at 3-month follow-up. This study was registered in Chictr...
April 24, 2024: Cardiovascular Revascularization Medicine: Including Molecular Interventions
https://read.qxmd.com/read/38664131/in-hospital-outcomes-with-extracorporeal-membrane-oxygenation-alone-versus-combined-with-percutaneous-left-ventricular-assist-device
#50
JOURNAL ARTICLE
Fatima Lakhani, Bertrand Ebner, Crystal Lihong Yan, Sukhpreet Kaur, Rosario Colombo, Mrudula Munagala
BACKGROUND: Veno-arterial extracorporeal membrane oxygenation (ECMO) is associated with increased afterload and hindered myocardial recovery. Adding a percutaneous left ventricular assist device (pLVAD) to ECMO is one strategy to unload the left ventricle. We evaluated in-hospital outcomes in cardiogenic shock patients treated with ECMO alone versus ECMO plus pLVAD. METHODS: We conducted a retrospective study using the National Inpatient Sample database from 2011 to 2019...
April 22, 2024: Cardiovascular Revascularization Medicine: Including Molecular Interventions
https://read.qxmd.com/read/38702260/application-of-the-academic-research-consortium-high-bleeding-risk-criteria-in-patients-treated-with-coronary-bioresorbable-polymer-everolimus-eluting-stents-insights-from-the-poem-trial
#51
JOURNAL ARTICLE
Antonio Popolo Rubbio, Luca Testa, Carlo A Pivato, Damiano Regazzoli, Raffaele Piccolo, Giovanni Esposito, Carmine Musto, Lorenzo Scalia, Andrea Pacchioni, Carlo Briguori, Luigi Lucisano, Leonardo De Luca, Federico Conrotto, Francesco Tartaglia, Alessia C Latini, Kamil Stankowski, Mauro Chiarito, Gennaro Sardella, Ciro Indolfi, Francesco Bedogni, Bernhard Reimers, Gianluigi Condorelli, Giulio G Stefanini
BACKGROUND: Previous studies have investigated a 1 to 6-month short dual antiplatelet therapy (S-DAPT) after percutaneous coronary intervention (PCI) with modern drug eluting-stents to reduce bleeding events. OBJECTIVES: To investigate cardiovascular outcomes in patients at high bleeding risk (HBR) according to the Academic Research Consortium for High Bleeding Risk (ARC-HBR) criteria after PCI with the Synergy bioresorbable-polymer everolimus-eluting stents (EES)...
April 16, 2024: Cardiovascular Revascularization Medicine: Including Molecular Interventions
https://read.qxmd.com/read/38670866/feasibility-and-technicality-of-aortic-valve-lithotripsy-facilitate-balloon-valvuloplasty-in-patients-with-severe-aortic-stenosis-unsuitable-for-immediate-valvular-replacement
#52
JOURNAL ARTICLE
Jonathan X Fang, Brian P O'Neill, Dee Dee Wang, Gennaro Giustino, Claudia Lama von Buchwald, James C Lee, Pedro Engel Gonzalez, Tiberio M Frisoli, William W O'Neill, Pedro A Villablanca
BACKGROUND: Aortic valve lithotripsy can fragment aortic valve calcium deposits and potentially restore leaflet pliability in animal model and ex-vivo, but clinical data is limited. Transcatheter aortic valve implantation (TAVR) might not be feasible as an urgent procedure in critically ill patients. Balloon valvuloplasty has the major limitation of valve recoil and inducing aortic regurgitation. AIMS: To determine the clinical feasibility of aortic valve lithotripsy-facilitated balloon valvuloplasty in patients with severe aortic stenosis unsuitable for valvular replacement...
April 16, 2024: Cardiovascular Revascularization Medicine: Including Molecular Interventions
https://read.qxmd.com/read/38664132/editorial-bifurcation-angle-in-bifurcation-intervention-does-it-matter
#53
EDITORIAL
Muhammad S Pir, Ion S Jovin
No abstract text is available yet for this article.
April 16, 2024: Cardiovascular Revascularization Medicine: Including Molecular Interventions
https://read.qxmd.com/read/38631937/2023-acc-aha-chronic-coronary-disease-guideline-an-opportunity-to-reestablish-coronary-artery-bypass-recommendations
#54
JOURNAL ARTICLE
Adnaldo da Silveira Maia, Magaly Arrais Dos Santos
Coronary artery bypass (CABG) has evolved over the decades, supported by scientific evidence from robust studies. The downgrade of the recommendation for CABG in patients with multivessel coronary artery disease proposed by the 2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization and the 2023 ACC/AHA Chronic Coronary Disease Guidelines has brought this discussion to the fore, with prestigious cardiothoracic surgery societies such as AATS and STS not supporting these recommendations. The purpose of this article is to broaden this discussion in light of published studies...
April 16, 2024: Cardiovascular Revascularization Medicine: Including Molecular Interventions
https://read.qxmd.com/read/38677895/frequency-of-ventriculography-during-left-heart-catheterization-for-radial-vs-femoral-access
#55
LETTER
Ilan Merdler, Brian C Case, Matteo Cellamare, Sukhdeep Bhogal, Pavan K Reddy, Cheng Zhang, Itsik Ben-Dor, Ron Waksman
BACKGROUND: Radial artery access has been used for left heart catheterization (LHC) and percutaneous coronary intervention (PCI) for over 30 years. This method has gained popularity among operators due to superficial vessel anatomy, allowing for easy accessibility and compressibility, resulting in effective hemostasis. METHODS: We conducted a retrospective analysis of patients who underwent PCI due to ST-elevation myocardial infarction (STEMI), non-ST-elevation acute coronary syndrome (NSTE-ACS), and chest pain (stable angina) from November 2013 to February 2023...
April 15, 2024: Cardiovascular Revascularization Medicine: Including Molecular Interventions
https://read.qxmd.com/read/38641439/how-much-does-cmd-cost-before-it-is-diagnosed
#56
EDITORIAL
Arnold H Seto, David M Tehrani
No abstract text is available yet for this article.
April 15, 2024: Cardiovascular Revascularization Medicine: Including Molecular Interventions
https://read.qxmd.com/read/38616461/emerging-trends-in-nationwide-mortality-limb-loss-and-resource-utilization-for-critical-limb-ischemia-in-young-adults
#57
JOURNAL ARTICLE
Fidelis Uwumiro, Victory Okpujie, Chikodili Nebuwa, Uwakmfonabasi Umoudoh, Evaristus Asobara, Emmanuel Aniaku, Golibe Makata, John Olukorode
BACKGROUND/OBJECTIVES: Recent trends indicate a rise in the incidence of critical limb ischemia (CLI) among younger adults. This study examines trends in CLI hospitalization and outcomes among young adults with peripheral arterial disease (PAD) in the United States. METHODS: Adult hospitalizations (18-40 years) for PAD/CLI were analyzed from the 2016-2020 nationwide inpatient sample database using ICD-10 codes. Rates were reported per 1000 PAD or 100,000 cardiovascular disease admissions...
April 14, 2024: Cardiovascular Revascularization Medicine: Including Molecular Interventions
https://read.qxmd.com/read/38658269/impact-of-sex-on-myocardial-perfusion-following-percutaneous-coronary-intervention-of-chronic-total-coronary-occlusions
#58
JOURNAL ARTICLE
Yvemarie B O Somsen, Ruben W de Winter, Stefan P Schumacher, Anna van Veelen, Pepijn A van Diemen, Ruurt A Jukema, Roel Hoek, Wynand J Stuijfzand, Ibrahim Danad, Jos W R Twisk, Niels J Verouden, Yolande Appelman, Alexander Nap, Sebastiaan A Kleijn, José P Henriques, Paul Knaapen
OBJECTIVES: We sought to investigate the impact of sex on myocardial perfusion changes following chronic total coronary occlusion (CTO) percutaneous coronary intervention (PCI) as measured by [15 O]H2 O positron-emission tomography (PET) perfusion imaging. BACKGROUND: CTO PCI has been associated with an increase in myocardial perfusion, yet females are less likely to undergo revascularization. As such, data on the impact of sex on myocardial perfusion following CTO PCI is scarce...
April 13, 2024: Cardiovascular Revascularization Medicine: Including Molecular Interventions
https://read.qxmd.com/read/38724408/comparing-planned-versus-ad-hoc-coronary-microvascular-assessment-early-findings-from-the-coronary-microvascular-disease-registry
#59
JOURNAL ARTICLE
Ilan Merdler, Nadjat Bazarbashi, Giorgio A Medranda, Cheng Zhang, Sevket Tolga Ozturk, Vaishnavi Sawant, Itsik Ben-Dor, Ron Waksman, Hayder D Hashim, Brian C Case
BACKGROUND: Coronary microvascular dysfunction (CMD) is an etiology for angina with non-obstructive coronary disease. However, the initial adoption of CMD assessment, whether planned or conducted ad hoc, is limited. We characterize planned and ad hoc CMD assessments and highlight evolving trends of a CMD referral center. METHODS: We analyzed outpatient data from the Coronary Microvascular Disease Registry from 2021 to 2023. Patients were categorized into planned or ad hoc CMD assessment groups, and baseline characteristics, hospital stay, medications, and physiological measurements were compared...
April 12, 2024: Cardiovascular Revascularization Medicine: Including Molecular Interventions
https://read.qxmd.com/read/38616462/outcomes-in-patients-with-low-flow-very-low-gradient-aortic-stenosis-a-long-term-follow-up
#60
LETTER
Lakshay Chopra, Carlo Mannina, Hiroki Ueyama, Jacqueline Mirza, Joseph Maenza, Ankur Dalsania, Francesca R Prandi, Edgar Argulian, Samin Sharma, Annapoorna Kini, Stamatios Lerakis
No abstract text is available yet for this article.
April 12, 2024: Cardiovascular Revascularization Medicine: Including Molecular Interventions
journal
journal
40959
3
4
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.